CUFinder

Steven Gabardi

Steven Gabardi

Harvard University

H-index: 34

North America-United States

Contact Steven Gabardi

About Steven Gabardi

Steven Gabardi, With an exceptional h-index of 34 and a recent h-index of 23 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Transplant Pharmacology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Potential effects of remdesivir on tacrolimus exposure in transplant recipients with COVID-19 infection

A review of direct-acting oral anticoagulants and their use in solid organ transplantation

426.1: Dyslipidemia in Kidney Transplant Recipients: Is It Time for A Change in Strategy?

Immunosuppression in the age of precision medicine

Implementing a regional standardized BK polyomavirus screening protocol across eleven transplant centres

Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients

Unraveling the genomic architecture of the CYP3A locus and ADME genes for personalized tacrolimus dosing

Novel approaches to management of hyperkalaemia in kidney transplantation

Steven Gabardi Information

University

Position

Abdominal Organ Transplant Clinical Specialist, Brigham and Women's Hospital

Citations(all)

3909

Citations(since 2020)

1404

Cited By

3145

hIndex(all)

34

hIndex(since 2020)

23

i10Index(all)

57

i10Index(since 2020)

39

Email

University Profile Page

Google Scholar

Steven Gabardi Skills & Research Interests

Transplant Pharmacology

Top articles of Steven Gabardi

Potential effects of remdesivir on tacrolimus exposure in transplant recipients with COVID-19 infection

Kidney International Reports

2023/7/1

Steven Gabardi
Steven Gabardi

H-Index: 22

Miae Kim
Miae Kim

H-Index: 7

A review of direct-acting oral anticoagulants and their use in solid organ transplantation

2022/11/1

Miae Kim
Miae Kim

H-Index: 7

Jean M Connors
Jean M Connors

H-Index: 30

Steven Gabardi
Steven Gabardi

H-Index: 22

426.1: Dyslipidemia in Kidney Transplant Recipients: Is It Time for A Change in Strategy?

Transplantation

2022/9/1

Jay Pandav
Jay Pandav

H-Index: 1

Steven Gabardi
Steven Gabardi

H-Index: 22

Anil Chandraker
Anil Chandraker

H-Index: 30

Immunosuppression in the age of precision medicine

2022/1/1

Steven Gabardi
Steven Gabardi

H-Index: 22

Implementing a regional standardized BK polyomavirus screening protocol across eleven transplant centres

Transplant international

2021/12

Ralph Rogers
Ralph Rogers

H-Index: 4

Steven Gabardi
Steven Gabardi

H-Index: 22

Nitender Goyal
Nitender Goyal

H-Index: 9

Martha Pavlakis
Martha Pavlakis

H-Index: 23

Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients

2021/12/1

Steven Gabardi
Steven Gabardi

H-Index: 22

Elani Streja
Elani Streja

H-Index: 41

Kamyar Kalantar-Zadeh
Kamyar Kalantar-Zadeh

H-Index: 93

Unraveling the genomic architecture of the CYP3A locus and ADME genes for personalized tacrolimus dosing

Transplantation

2021/10/1

Steven Gabardi
Steven Gabardi

H-Index: 22

Novel approaches to management of hyperkalaemia in kidney transplantation

2021/1/1

John Rizk
John Rizk

H-Index: 4

Steven Gabardi
Steven Gabardi

H-Index: 22

Kamyar Kalantar-Zadeh
Kamyar Kalantar-Zadeh

H-Index: 93

Expecting the unexpected: COVID-19 in kidney transplant recipients within United Network for Organ Sharing Region 1

2020/10/1

Some Aspects of Aging Are Advantageous: Elderly Organ Recipients May Get Away With Less Immunosuppression

Transplantation

2020/3/1

Steven Gabardi
Steven Gabardi

H-Index: 22

See List of Professors in Steven Gabardi University(Harvard University)